Tg Therapeutics reported $455.07M in Current Assets for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Assets Change
Acceleron Pharma XLRN:US $ 696.61M 21.16M
Amgen AMGN:US $ 24380M 5281M
Ardelyx ARDX:US $ 153.38M 33.11M
Arena Pharmaceuticals ARNA:US $ 790.92M 199.52M
Arrowhead Research ARWR:US $ 384.6M 141.36M
Bayer BAYN:GR 31.94B 506M
Biogen BIIB:US $ 7162.3M 21.4M
Corcept Therapeutics CORT:US $ 401.9M 9.37M
Curis CRIS:US $ 134.95M 21.58M
Dynavax Technologies DVAX:US $ 852.67M 268.76M
Gilead Sciences GILD:US $ 14200M 275M
Infinity Pharmaceuticals INFI:US $ 91.93M 7.75M
Karyopharm Therapeutics KPTI:US $ 241.58M 31.92M
Novartis NOVN:VX 26.25B 2.45B
Novavax NVAX:US $ 2174.18M 180.81M
Ptc Therapeutics PTCT:US $ 1011.14M 55.09M
Puma Biotechnology PBYI:US $ 136.92M 30.83M
Regeneron Pharmaceuticals REGN:US $ 13775.4M 437.8M
Spectrum Pharmaceuticals SPPI:US $ 140M 25.71M
Verastem VSTM:US $ 108.76M 6M
Vertex Pharmaceuticals VRTX:US $ 8852.54M 395.03M
Ziopharm Oncology ZIOP:US $ 96.55M 7.15M